Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 34

Results For "March"

845 News Found

Sharon Bio-Medicine resumes operations
News | March 23, 2024

Sharon Bio-Medicine resumes operations

Operations of Line II was stopped due to a fire incident earlier


Evonik Vland Biotech JV commences operations
Biotech | March 16, 2024

Evonik Vland Biotech JV commences operations

Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China


Lupin receives Form 483 with 1 observation from USFDA after inspection at Aurangabad facility
Drug Approval | March 16, 2024

Lupin receives Form 483 with 1 observation from USFDA after inspection at Aurangabad facility

The company is confident of addressing the concern raised by the USFDA


Indranil Sen, CFO, Biocon resigned
People | March 16, 2024

Indranil Sen, CFO, Biocon resigned

Sen spent a decade with Biocon and held various key roles,


Merck completes acquisition of Harpoon Therapeutics
News | March 12, 2024

Merck completes acquisition of Harpoon Therapeutics

Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager


LVPEI observes World Glaucoma Week
Healthcare | March 11, 2024

LVPEI observes World Glaucoma Week

Vision loss due to Glaucoma can be prevented if it is detected and treated early


Women's integral role in India's US$ 5 trillion ambition
News | March 11, 2024

Women's integral role in India's US$ 5 trillion ambition

Women emerge as the cornerstone of this monumental undertaking


Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO
People | March 09, 2024

Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO

Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function


Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility
Drug Approval | March 09, 2024

Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility

The inspection was concluded with few procedural observations


USFDA conducts inspection at Alembic Pharmaceuticals' Panelav oncology formulation facility
Drug Approval | March 09, 2024

USFDA conducts inspection at Alembic Pharmaceuticals' Panelav oncology formulation facility

The company will provide comprehensive response to USFDA for the observations